500 related articles for article (PubMed ID: 19778001)
1. Dissecting the inhibition mechanism of cytosolic versus transmembrane carbonic anhydrases by ESR.
Ciani L; Cecchi A; Temperini C; Supuran CT; Ristori S
J Phys Chem B; 2009 Oct; 113(42):13998-4005. PubMed ID: 19778001
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.
Cecchi A; Ciani L; Winum JY; Montero JL; Scozzafava A; Ristori S; Supuran CT
Bioorg Med Chem Lett; 2008 Jun; 18(12):3475-80. PubMed ID: 18513964
[TBL] [Abstract][Full Text] [Related]
3. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
6. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
9. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
Knaus EE; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
Sarikaya B; Ceruso M; Carta F; Supuran CT
Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
[TBL] [Abstract][Full Text] [Related]
12. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
[TBL] [Abstract][Full Text] [Related]
13. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
Saluja AK; Tiwari M; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
Franchi M; Vullo D; Gallori E; Pastorek J; Russo A; Scozzafava A; Pastorekova S; Supuran CT
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):333-8. PubMed ID: 14567548
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
D'Ambrosio K; Vitale RM; Dogné JM; Masereel B; Innocenti A; Scozzafava A; De Simone G; Supuran CT
J Med Chem; 2008 Jun; 51(11):3230-7. PubMed ID: 18481843
[TBL] [Abstract][Full Text] [Related]
17. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Ibrahim DA; Lasheen DS; Zaky MY; Ibrahim AW; Vullo D; Ceruso M; Supuran CT; Abou El Ella DA
Bioorg Med Chem; 2015 Aug; 23(15):4989-4999. PubMed ID: 26048024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
